REDHILL BIOPHARMA LTD. Finance Costs
REDHILL BIOPHARMA LTD. (RDHL) reported Finance Costs of $1.09 million for the 6-month period ending 2025-06-30, per its 6-K filed 2025-09-05.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:FinanceCosts · last filed 2025-09-05
- REDHILL BIOPHARMA LTD. finance costs for the quarter ending 2022-06-30 was $4.21M, a 0.85% decline year-over-year.
- REDHILL BIOPHARMA LTD. finance costs for the quarter ending 2021-06-30 was $4.25M, a 16.28% increase year-over-year.
- REDHILL BIOPHARMA LTD. finance costs for the quarter ending 2020-06-30 was $3.65M, a 4839.19% increase year-over-year.
- REDHILL BIOPHARMA LTD. finance costs for the quarter ending 2019-06-30 was $74.00K, a 95.69% decline year-over-year.
| Period end | Finance Costs 3 month | Finance Costs 6 month | Finance Costs 12 month |
|---|---|---|---|
| 2025-06-30 | $1.09M 6-K · filed 2025-09-05 | ||
| 2024-12-31 | $2.06M 20-F · filed 2025-04-10 | ||
| 2024-06-30 | $1.80M 6-K · filed 2025-09-05 | ||
| 2023-12-31 | $9.61M 20-F · filed 2025-04-10 | ||
| 2023-06-30 | $2.35M 6-K · filed 2024-08-29 | ||
| 2022-12-31 | $42.39M 20-F · filed 2025-04-10 | ||
| 2022-06-30 | $4.21M 6-K · filed 2022-11-07 | $8.12M 6-K · filed 2023-08-17 | |
| 2021-12-31 | $16.66M 20-F · filed 2024-04-08 | ||
| 2021-06-30 | $4.25M 6-K · filed 2022-11-07 | $8.98M 6-K · filed 2022-11-07 | |
| 2020-12-31 | $12.76M 20-F · filed 2023-04-28 | ||
| 2020-06-30 | $3.65M 6-K · filed 2021-08-26 | $4.01M 6-K · filed 2021-08-26 | |
| 2019-12-31 | $438.00K 20-F · filed 2022-03-17 | ||
| 2019-06-30 | $74.00K 6-K · filed 2020-08-13 | $133.00K 6-K · filed 2020-08-13 | |
| 2018-12-31 | $167.00K 20-F · filed 2021-03-18 | ||
| 2018-06-30 | $1.72M 6-K · filed 2019-07-23 | $1.74M 6-K · filed 2019-07-23 | |
| 2017-12-31 | $77.00K 20-F · filed 2020-03-04 | ||
| 2017-06-30 | $7.00K 6-K · filed 2018-08-30 | $56.00K 6-K · filed 2018-08-30 | |
| 2016-12-31 | $375.00K 20-F · filed 2019-02-26 | ||
| 2015-12-31 | $212.00K 20-F · filed 2018-02-22 |